Investigating the Relationship between the Severity of Restless Leg Syndrome and the Type of Dialysis and Blood Parameters of Calcium, Phosphorus, Parathyroid Hormone, and Vitamin D

Document Type : Original Article (s)

Authors

1 Medical Student Specializing in Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Assistant Professor of Kidney Diseases (Adults), Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

10.48305/jims.v42.i763.0272

Abstract

Background: Restless leg syndrome (RLS) is a common complication of chronic kidney disease (CKD). Due to the ambiguity of the pathophysiology of this condition, the effect of the dialysis method and the relationship between the serum level of blood parameters and the severity of RLS incidence have not been well defined. In this study; the relationship between the dialysis method and the effect of blood calcium, phosphorus, parathyroid hormone, and vitamin D on the severity of restless leg syndrome has been investigated.
Methods: In this cross-sectional study, 165 hemodialysis patients and 110 peritoneal dialysis patients were included by referring to the dialysis department of Al-Zahra and Khurshid Hospital in Isfahan. Restless leg syndrome was diagnosed and ranked using international criteria, then the parameters of vitamin D, calcium, phosphorus, and parathyroid hormone were recorded and analyzed based on the results of the tests.
Findings: The results of the present study show that the dialysis method does not affect the frequency and severity of restless leg syndrome. In this research, the multiple regression model did not fit well in the hemodialysis and peritoneal dialysis groups. Based on the results, the correlation values between calcium, PTH, and serum phosphorus variables in the two groups were positive, and the relationship between vitamin D and restless legs syndrome score was negative (P < 0.05).
Conclusion: Regularly monitoring biochemical markers such as vitamin D, phosphorus, calcium, and PTH levels in the blood serum of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) patients plays a crucial role in reducing the occurrence of restless leg syndrome in CKD patients.

Highlights

Elham Babaei: Google Scholar, PubMed

Sahar Vahddat: Google Scholar, PubMed

Keywords

Main Subjects

References

  1. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet 2017; 389(10075): 1238-52.
  2. Liu C, Li J, Zhang Y, Philip A, Shi E, Chi X, et al. Influence of glucose fermentation on CO2 assimilation to acetate in homoacetogen Blautia coccoides GA-1. J Ind Microbiol Biotechnol 2015; 42(9): 1217-24.
  3. Yokoyama K, Taniguchi M, Fukagawa M. A Japanese approach for CKD-MBD. Kidney Int Suppl (2011) 2013; 3(5): 451-6.
  4. Safarpour Y, Vaziri ND, Jabbari B. Restless legs syndrome in chronic kidney disease—a systematic review. Tremor Other Hyperkinet Mov (N Y) 2023; 13: 10.
  5. Huang C-W, Lee MJ, Wang LJ, Lee PT, Tu YK, Hsu CW, et al. Comparative efficacy and acceptability of treatments for restless legs syndrome in end-stage renal disease: a systematic review and network meta-analysis. Nephrology Dialysis Transplantation 2020; 35(9): 1609-18.
  6. Sorbi MH, Baharvand B, Dehghanniry F, Gol Mohammadi Shooroki MR, Jafarzadeh M. Prevalence of restless legs syndrome in Iranian patients under hemodialysis: a systematic review and meta-analysis study [in Persian]. J Shahid Sadoughi Uni Med Sci 2022; 30(3): 4620-32.
  7. Kavanagh D, Siddiqui S, Geddes CC. Restless legs syndrome in patients on dialysis. American Journal of Kidney Diseases 2004; 43(5): 763-71.
  8. 8Anyfantakis D, Katsanikaki F, Symvoulakis EK. Diabetic neuropathy and restless legs syndrome: can a known chronic condition slow down our diagnostic way of thinking? A case report and a short literature overview. Med Pharm Rep 2020; 93(3): 297-300.
  9. Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, Pantzaris MC, Stefanidis I, Sakkas GK. Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review. Kidney Int 2014; 85(6): 1275-82.
  10. Matar SG, El-Nahas ZS, Aladwan H, Hasanin M, Elsayed SM, Nourelden AZ, et al. Restless leg syndrome in hemodialysis patients: a narrative review. Neurologist 2022; 27(4): 194-202.
  11. Janzen L, Rich JA, Vercaigne LM. An overview of levodopa in the management of restless legs syndrome in a dialysis population: pharmacokinetics, clinical trials, and complications of therapy. Ann Pharmacother 1999; 33(1): 86-92.
  12. Al-Jahdali H. A comparison of sleep disturbances and sleep apnea in patients on hemodialysis and chronic peritoneal dialysis. Saudi J Kidney Dis Transpl 2011; 22(5): 922-30.
  13. Merlino G, Lorenzut S, Romano G, Sommaro M, Fontana A, Montanaro D, et al. Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis. Neurol Sci 2012; 33(6): 1311-8.
  14. Japaridze G, Kasradze S, Maisuradze L, Popp R, Wetter T. The restless legs syndrome (review). Georgian Med News 2018(285): 74-81.
  15. Habibzade H, Khalkhali H, Ghaneii R. Study of the relationship between restless legs syndrome and sleep disturbance among patients in Critical Care Units [in Persian]. Iran J Crit Care Nurs 2011; 4(3): 153-8.
  16. de Menezes AF, Motta DRMdS, Carvalho FOd, Santana-Santos E, de Andrade Júnior MP, Figueirôa MF, et al. Restless legs syndrome in dialysis patients: does the dialysis modality influence its occurrence and severity? I Int J Nephrol 2018; 2018: 1414568.
  17. Shahidi A, Abbaspour S, Namjo M, Najafzadeh A. Restless legs syndrome in hemodialysis patients. Journal of Medical Council of Islamic Republic of Iran 2010; 28(1): 29-127.
  18. Molahosseini Sh, Mohammadzadeh Sh, Kamali P, Tavakkoli Shooshtari M. Frequency of sleep disorder and restless legs syndrome in patients referring to hemodialysis units in university hospitals in Tehran in 2003 [in Persian]. Medical Sciences 2005; 15(1): 27-30.
  19. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160(14): 2137-41.
  20. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002; 53(1): 547-54.
  21. Araujo SMHA, de Bruin VMS, Nepomuceno LA, Maximo ML, de Francesco Daher E, Ferrer DPC, et al. Restless legs syndrome in end-stage renal disease: clinical characteristics and associated comorbidities. Sleep Med 2010; 11(8): 785-90.
  22. Amiri M, Bidaki R, Avazbakhsh M H, Mirhosseini H, Yamola M. Prevalence and correlates of restless legs syndrome in chronic renal failure patients undergoing hemodialysis [in Persian]. Koomesh 2019; 21(3): 493-7.
  23. Oran M, Unsal C, Albayrak Y, Tulubas F, Oguz K, Avci O, et al. Possible association between vitamin D deficiency and restless legs syndrome. Neuropsychiatr Dis Treat 2014; 10: 953-8.
  24. Yang D, Liu Y, Chu Y, Yang Q, Jiang W, Chen F, et al. Association between vitamin D receptor gene FokI polymorphism and skeletal fluorosis of the brick-tea type fluorosis: a cross sectional, case control study. BMJ Open 2016; 6(11): e011980.
  25. Gao Q, Kou T, Zhuang B, Ren Y, Dong X, Wang Q. The association between vitamin D deficiency and sleep disorders: a systematic review and meta-analysis. Nutrients 2018; 10(10): 1395.
  26. Wali S, Alsafadi S, Abaalkhail B, Ramadan I, Abulhamail B, Kousa M, et al. The association between vitamin D level and restless legs syndrome: a population-based case-control study. J Clin Sleep Med 2018; 14(4): 557-64.
  27. Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Journal of the American Society of Nephrology 2005; 16(6): 1788-93.
  28. Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi Y, Fukuhara S, et al. Association of mineral metabolism factors with all‐cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study. Hemodial Int 2007; 11(3): 340-8.
  29. Danese MD, Belozeroff V, Smirnakis K, Rothman KJ. Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol 2008; 3(5): 1423-9.
Journal of Isfahan Medical School
Volume 42, Issue 763
3rd Week, June
May and June 2024
Pages 272-279

Files

History

  • Receive Date: 04 December 2023
  • Accept Date: 23 July 2024

Share

How to cite

Statistics